Bio-Rad Laboratories, Inc. Stock NYSE
Stocks
BIO.B
US0905721082
Medical Equipment, Supplies & Distribution
|
Market Closed -
NYSE
04:10:00 21/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 365.08 USD | +8.33% |
|
+8.33% | +17.50% |
| 08-07 | RBC Adjusts PT on Bio-Rad Laboratories to $390 From $370, Maintains Outperform Rating | MT |
| 08-05 | RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating | MT |
| Market Cap | 10.27B 8.82B 8.28B 7.56B 14.26B 980B 14.33B 97.93B 37.95B 494B 38.57B 37.73B 1,637B | P/E 2026 * |
46.7x | P/E 2027 * | 45.7x |
|---|---|---|---|---|---|
| Enterprise Value | 9.52B 8.17B 7.67B 7.01B 13.22B 908B 13.29B 90.79B 35.19B 458B 35.76B 34.98B 1,518B | EV / Sales 2026 * |
3.7x | EV / Sales 2027 * | 3.53x |
| Free-Float |
60.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | +8.33% | ||
| 1 week | +8.33% | ||
| Current month | +18.01% | ||
| 1 month | +18.01% | ||
| 3 months | +36.51% | ||
| 6 months | +35.78% | ||
| Current year | +17.50% |
| 1 month | 337 |  | 365.08 |
| Current year | 244.54 | | 365.08 |
| 1 year | 244.54 | | 365.08 |
| 3 years | 0 | | 373.78 |
| 5 years | 0 | | 818.6 |
| 10 years | 0 | | 818.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +8.33% | +8.33% | - | - | 10.31B | |
| -1.75% | -0.29% | -13.29% | +9.49% | 201B | |
| +0.97% | -2.24% | -0.17% | +11.96% | 117B | |
| -0.08% | +3.37% | +13.15% | +82.63% | 62.6B | |
| -1.38% | -3.03% | +27.96% | +54.61% | 52.49B | |
| +0.23% | +1.39% | -1.99% | -32.07% | 51.69B | |
| -0.22% | -1.02% | +16.87% | -11.71% | 33.65B | |
| -2.97% | +1.98% | - | - | 31.27B | |
| +0.41% | -0.81% | +43.12% | -11.13% | 24.52B | |
| +0.12% | +4.09% | -2.76% | +19.81% | 24.05B | |
| Average | +0.37% | -0.05% | +10.36% | +15.45% | 66.43B | |
| Weighted average by Cap. | -0.50% | -0.40% | +1.86% | +16.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.21B 2.07B 1.89B 3.57B 245B 3.59B 24.53B 9.51B 124B 9.66B 9.45B 410B | 2.63B 2.26B 2.12B 1.94B 3.66B 251B 3.67B 25.11B 9.73B 127B 9.89B 9.67B 420B |
| Net income | 225M 193M 181M 166M 312M 21.46B 314M 2.15B 831M 10.83B 845M 826M 35.86B | 230M 197M 185M 169M 319M 21.94B 321M 2.19B 850M 11.07B 864M 845M 36.66B |
| Net Debt | -749M -643M -603M -551M -1.04B -71.44B -1.05B -7.14B -2.77B -36.04B -2.81B -2.75B -119B | -965M -829M -778M -710M -1.34B -92.08B -1.35B -9.2B -3.57B -46.45B -3.62B -3.55B -154B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BIO.B Stock
Select your edition
All financial news and data tailored to specific country editions
